Cagrilintide 5mg Peptide Canada

Amylin‑Analogue Research Peptide for Hormonal Signalling & Receptor‑Pathway Studies (Canada)

Cagrilintide is a research‑grade synthetic long‑chain peptide analogue of amylin, engineered for laboratory research involving amylin receptor (AMYR) signalling and associated metabolic pathways. It is widely referenced in experimental models exploring hormone‑mediated signalling, receptor activation dynamics, and peptide stability in controlled environments.

Supplied by BlueNex Labs, Cagrilintide is available as a lyophilized research peptide in 5 mg fill size, with a published lot file when one exists, analytical consistency, and audit‑safe Research‑Use‑Only (RUO) labelling, supporting advanced experimental workflows in Canadian research settings.

Cagrilintide is designed to support investigation of amylin‑associated receptor signalling and its interaction within broader hormonal communication networks.

In controlled laboratory settings, Cagrilintide is commonly referenced in studies examining:

• Amylin receptor (AMYR) signalling pathways
• Hormone‑mediated receptor activation models
• Peptide‑receptor interaction kinetics
• Signal transduction and receptor modulation
• Comparative analysis of native vs. analogue peptide structures

Its analogue design enables detailed study of receptor‑binding behaviour and signalling pathway responses.

Cagrilintide is a synthetic amylin‑analogue research peptide developed to support laboratory investigations involving:

• Amylin receptor (AMYR) activation
• Hormone‑linked signalling systems
• Peptide structure–function relationships

This receptor‑focused approach allows researchers to explore signalling behaviour within controlled experimental systems.

In research contexts, Cagrilintide supports studies involving:

• Receptor‑pathway signalling analysis
• Hormonal communication networks
• Peptide binding affinity and selectivity
• Integrated pathway response modelling

🔵 AMYR‑Linked Signalling

• Referenced in studies examining amylin‑associated receptor activity
• Used in models exploring receptor‑mediated signalling pathways
• Supports investigation of intracellular signalling cascades

🟣 Hormonal Signalling Integration

• Applied in research examining multi‑hormone pathway interaction
• Supports studies of receptor cross‑talk and signalling modulation
• Used in comparative signalling pathway models

🔗 Receptor‑Level Analysis

• Enables evaluation of receptor binding and activation patterns
• Supports studies of ligand–receptor interaction dynamics
• Used in pathway‑specific vs. integrated response analysis

Type: Synthetic amylin‑analogue peptide

Form: Lyophilized powder

Available Fill Size: 5 mg

Identity Verification: Mass Spectrometry (MS)

Purity Analysis: HPLC / UPLC

Structural & Biochemical Notes

• Designed with structural modifications for enhanced stability
• Demonstrates consistent analytical behaviour in testing workflows
• Suitable for receptor‑binding and signalling pathway studies

Cagrilintide is commonly referenced in laboratory research involving:

• Amylin receptor signalling studies
• Hormone‑associated signalling pathway modelling
• Receptor–ligand binding and activation analysis
• Peptide analogue stability and degradation studies
• Structure–function evaluation of modified peptide analogues

Its focused receptor profile supports targeted signalling research within regulated laboratory environments.

• Store lyophilized peptide at −20 °C, protected from light and moisture
• Avoid repeated freeze–thaw cycles; aliquot according to your laboratory SOP

Batch Certificates of Analysis are listed in the certificates library when published. Match vial size and lot notes before assigning a lot to an assay.

Research use only. Not for human or veterinary use. No medical, cosmetic, or performance claims are made or implied.